BRPI0814864A2 - Utilização de uma quantidade eficaz de hesperidina ou um de seus derivados e processo cosmético de tratamento e/ou prevenção das peles flácidas e/ou estrias. - Google Patents

Utilização de uma quantidade eficaz de hesperidina ou um de seus derivados e processo cosmético de tratamento e/ou prevenção das peles flácidas e/ou estrias.

Info

Publication number
BRPI0814864A2
BRPI0814864A2 BRPI0814864-3A2A BRPI0814864A BRPI0814864A2 BR PI0814864 A2 BRPI0814864 A2 BR PI0814864A2 BR PI0814864 A BRPI0814864 A BR PI0814864A BR PI0814864 A2 BRPI0814864 A2 BR PI0814864A2
Authority
BR
Brazil
Prior art keywords
hesperidine
flakes
strikes
prevention
derivatives
Prior art date
Application number
BRPI0814864-3A2A
Other languages
English (en)
Inventor
Audrey Gueniche
Isabelle Castiel
Original Assignee
Oreal
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Nestec Sa filed Critical Oreal
Publication of BRPI0814864A2 publication Critical patent/BRPI0814864A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0814864-3A2A 2007-08-02 2008-08-01 Utilização de uma quantidade eficaz de hesperidina ou um de seus derivados e processo cosmético de tratamento e/ou prevenção das peles flácidas e/ou estrias. BRPI0814864A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756898A FR2919501B1 (fr) 2007-08-02 2007-08-02 Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
PCT/FR2008/051453 WO2009022077A2 (fr) 2007-08-02 2008-08-01 Utilisation d'hespéridine ou de l'un de ses dérivés pour la prévention et/ou le traitement des peaux relâchées

Publications (1)

Publication Number Publication Date
BRPI0814864A2 true BRPI0814864A2 (pt) 2014-09-30

Family

ID=39126227

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814864-3A2A BRPI0814864A2 (pt) 2007-08-02 2008-08-01 Utilização de uma quantidade eficaz de hesperidina ou um de seus derivados e processo cosmético de tratamento e/ou prevenção das peles flácidas e/ou estrias.

Country Status (9)

Country Link
US (1) US20100305053A1 (pt)
EP (1) EP2170466B1 (pt)
CN (1) CN101790400B (pt)
BR (1) BRPI0814864A2 (pt)
CA (1) CA2695235C (pt)
ES (1) ES2527502T3 (pt)
FR (1) FR2919501B1 (pt)
MX (1) MX2010001300A (pt)
WO (1) WO2009022077A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
ES2461791T3 (es) * 2007-09-04 2014-05-21 L'oréal Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel
CN102266320B (zh) * 2010-07-20 2015-06-17 浙江养生堂天然药物研究所有限公司 橙皮素的新用途
GB201106958D0 (en) * 2011-04-27 2011-06-08 Stuff Of Life Ltd Formulation
US20120277171A1 (en) * 2011-04-28 2012-11-01 Jose Luis Silva Martinot Warmi®, natural alternative for the treatment of menopause
FR2980360B1 (fr) * 2011-09-27 2013-10-11 Oreal Utilisation cosmetique de l'hesperidine ou de l'un de ses derives dans la prevention et/ou le traitement des odeurs corporelles.
EP3226976A1 (en) 2014-12-04 2017-10-11 Mary Kay, Inc. Topical skin care composition comprising trifluoroacetyl tripeptide-2
TW201642849A (zh) * 2015-03-31 2016-12-16 阿爾塞斯商業集團國際有限公司 包括芝麻素之組成物、其製造方法及用於皮膚抗老化及皮膚美白應用之用途
CN109512710A (zh) 2017-09-18 2019-03-26 玫琳凯有限公司 化妆品组合物及方法
KR20220088874A (ko) * 2019-10-30 2022-06-28 토요 슈가 리파이닝 컴퍼니 리미티드 셀룰라이트 개선용 피부 외용제 및 셀룰라이트 개선 방법
CN110731912A (zh) * 2019-11-20 2020-01-31 广州瑞誉化工科技有限公司 一种美白抗衰老精华液

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US858784A (en) 1906-04-06 1907-07-02 Henry C Black Can-end crimping and seaming mechanism.
US3156355A (en) * 1962-02-02 1964-11-10 Jack A Wood Condiment packet
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
FR2578165B3 (fr) * 1985-01-22 1987-12-18 Chicouri Marcel Nouvelles pommades a action anticellulitique.
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
LU87109A1 (fr) * 1988-01-20 1989-08-30 Cird Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
AU639373B2 (en) * 1990-10-22 1993-07-22 Unilever Plc Cosmetic composition
US5110593A (en) * 1990-11-13 1992-05-05 Benford M Sue Irradication and treatment of diaper dermatitis and related skin disorders
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
JP3833775B2 (ja) 1996-06-26 2006-10-18 株式会社林原生物化学研究所 酵素処理ヘスペリジンおよびその製造方法ならびに酵素処理ヘスペリジンの使用方法
US6048712A (en) 1997-03-24 2000-04-11 Kabushiki Kaisha Hayashibara Process for producing α-monoglucosyl hesperidin-rich substance
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
DK0931543T3 (da) * 1997-12-19 2002-06-17 Merck Patent Gmbh Flerlagstabletter indeholdende probiotiske mikroorganismer såsom lactobacilli eller bifidobakterier
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
FR2781669B1 (fr) * 1998-07-31 2000-09-15 Lanatech Composition cosmetique incluant au moins un polysaccharide provenant de bacteries d'origine hydrothermale
JP3618296B2 (ja) * 1998-10-09 2005-02-09 株式会社ヤクルト本社 皮膚外用剤
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
DE10009424A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
JP4510376B2 (ja) * 2000-10-06 2010-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
US20020106388A1 (en) * 2000-11-24 2002-08-08 Pugliese Peter T. Formulation of flavones and isoflavones for treatment of cellulite
KR100858575B1 (ko) * 2000-12-19 2008-09-17 가부시키가이샤 야쿠루트 혼샤 피부 외용제 및 그 제조 방법
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
GB0119583D0 (en) * 2001-08-10 2001-10-03 Unilever Plc Cosmetic composition and method of treating skin
EP1327438A1 (de) * 2002-01-12 2003-07-16 Dr. Scheller Cosmetics AG kosmetische Zubereitung und ihre Verwendung
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
JP2005525348A (ja) * 2002-02-21 2005-08-25 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚のための光防護性の経口投与可能な組成物
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
CA2508712A1 (en) * 2002-12-13 2004-07-01 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
JP2007516937A (ja) * 2003-06-20 2007-06-28 コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ フラボノイドとω−置換Ｃ６〜Ｃ２２脂肪酸とのエステル
BRPI0417723A (pt) * 2003-12-18 2007-04-03 Nestec Sa composição para melhorar a saúde da pele, cabelo e tegumento contendo flavanonas
AU2005231443B2 (en) * 2004-04-01 2012-02-23 The General Hospital Corporation Method and apparatus for dermatological treatment and tissue reshaping
FR2869229B1 (fr) * 2004-04-26 2006-08-25 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
US7651860B2 (en) * 2004-12-17 2010-01-26 Enviro Tech Chemical Services, Inc. Method of analyzing low levels of peroxyacetic acid in water
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
WO2010013182A1 (en) * 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses

Also Published As

Publication number Publication date
CA2695235C (fr) 2014-09-23
CN101790400B (zh) 2015-10-21
MX2010001300A (es) 2010-04-30
US20100305053A1 (en) 2010-12-02
EP2170466A2 (fr) 2010-04-07
FR2919501B1 (fr) 2010-12-31
WO2009022077A2 (fr) 2009-02-19
WO2009022077A3 (fr) 2010-02-11
EP2170466B1 (fr) 2014-10-22
CA2695235A1 (fr) 2009-02-19
CN101790400A (zh) 2010-07-28
ES2527502T3 (es) 2015-01-26
FR2919501A1 (fr) 2009-02-06

Similar Documents

Publication Publication Date Title
BRPI0814864A2 (pt) Utilização de uma quantidade eficaz de hesperidina ou um de seus derivados e processo cosmético de tratamento e/ou prevenção das peles flácidas e/ou estrias.
BRPI0907422A2 (pt) Composições de limpeza e/ou tratamento
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
PT2963031T (pt) Pró-fármacos de tetrahidrocanabinol, composições compreendendo pró-fármacos de tetrahidrocanabinol e métodos de utilização dos mesmos
BRPI1005803A2 (pt) composição cosmética, processo de tratamento cosmético e kit com duas partes ou mais
BRPI0819361A2 (pt) Composição de tratamento de cabelos e agente de tratamento
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
HRP20160598T1 (hr) Bakterijski sastavi za prevenciju i liječenje degenerativne bolesti
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
BRPI0920026A2 (pt) método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.
BRPI0918670A2 (pt) composições e métodos para o tratamento de disordens mediados por ige
BRPI0813001A2 (pt) composto, método de tratamento ou profilaxia de dor neuropática e composição farmacêutica
BRPI0816836A2 (pt) Composições de limpeza e/ou tratamento
BRPI1008628A2 (pt) método de tratamento ou prevenção de arritmia cardíaca em um indivíduo
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
BRPI1010302A2 (pt) composições e métodos para tratamento, inibição ou prevenção do desenvolvimento de uma doença patogênica de planta e método de extermínio, inibição ou prevenção do desenvolvimento de um organismo
HUE061548T2 (hu) Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
BRPI0916235A2 (pt) composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
BR112012006938A2 (pt) processo de tratamento cosmético dos cabelos utilização do processo, dispositivos com vários compartimentos e composições cosméticas
BRPI0906975A2 (pt) Escova de dente para o tratamento e/ou detecção de micróbios
BR112012020719A2 (pt) formulação herbicida método de tratamento de plantas com herbicida método de aumento da eficácia de uma formulação herbicida, e, uso de uma composição
BR112012029870A2 (pt) composição cosmética e processo de tratamento cosmético para materiais queratínicas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM O ART. 13 E ART. 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: L'OREAL (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (C

Owner name: L'OREAL (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (CH)